These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10577563)

  • 1. Outcome of Hispanic patients treated with thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I and III trials. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.
    Cohen MG; Granger CB; Ohman EM; Stebbins AL; Grinfeld LR; Cagide AM; Elizari MV; Betriu A; Kong DF; Topol EJ; Califf RM
    J Am Coll Cardiol; 1999 Nov; 34(6):1729-37. PubMed ID: 10577563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials.
    Hudson MP; Granger CB; Topol EJ; Pieper KS; Armstrong PW; Barbash GI; Guerci AD; Vahanian A; Califf RM; Ohman EM
    Circulation; 2001 Sep; 104(11):1229-35. PubMed ID: 11551872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
    Labinaz M; Sketch MH; Stebbins AL; DeFranco AC; Holmes DR; Kleiman NS; Betriu A; Rutsch WR; Vahanian A; Topol EJ; Califf RM
    Am J Cardiol; 1996 Dec; 78(12):1338-44. PubMed ID: 8970403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of acute ST-segment elevation myocardial infarction in patients with prior coronary artery bypass surgery receiving thrombolytic therapy.
    Labinaz M; Sketch MH; Ellis SG; Abramowitz BM; Stebbins AL; Pieper KS; Holmes DR; Califf RM; Topol EJ
    Am Heart J; 2001 Mar; 141(3):469-77. PubMed ID: 11231447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient outcomes after fibrinolytic therapy for acute myocardial infarction at hospitals with and without coronary revascularization capability.
    Mehta RH; Criger DA; Granger CB; Pieper KK; Califf RM; Topol EJ; Bates ER
    J Am Coll Cardiol; 2002 Sep; 40(6):1034-40; discussion 1041-3. PubMed ID: 12354424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Mak KH; Moliterno DJ; Granger CB; Miller DP; White HD; Wilcox RG; Califf RM; Topol EJ
    J Am Coll Cardiol; 1997 Jul; 30(1):171-9. PubMed ID: 9207639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary revascularization surgery after myocardial infarction: impact of bypass surgery on survival after thrombolysis. GUSTO Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Tardiff BE; Califf RM; Morris D; Bates E; Woodlief LH; Lee KL; Green C; Rutsch W; Betriu A; Aylward PE; Topol EJ
    J Am Coll Cardiol; 1997 Feb; 29(2):240-9. PubMed ID: 9014973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of early sustained reperfusion in patients with prior myocardial infarction (the GUSTO-I trial). Global Utilization of Streptokinase and TPA for occluded arteries.
    Brieger DB; Mak KH; White HD; Kleiman NS; Miller DP; Vahanian A; Ross AM; Califf RM; Topol EJ
    Am J Cardiol; 1998 Feb; 81(3):282-7. PubMed ID: 9468068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial.
    White HD; Barbash GI; Califf RM; Simes RJ; Granger CB; Weaver WD; Kleiman NS; Aylward PE; Gore JM; Vahanian A; Lee KL; Ross AM; Topol EJ
    Circulation; 1996 Oct; 94(8):1826-33. PubMed ID: 8873656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolysis and Q wave versus non-Q wave first acute myocardial infarction: a GUSTO-I substudy. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries Investigators.
    Barbagelata A; Califf RM; Sgarbossa EB; Goodman SG; Stebbins AL; Granger CB; Suarez LD; Borruel M; Gates K; Starr S; Wagner GS
    J Am Coll Cardiol; 1997 Mar; 29(4):770-7. PubMed ID: 9091523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction: an analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (gusto I) and assessment of the safety of a new thrombolytic (assent 2) studies.
    Barbash GI; Birnbaum Y; Bogaerts K; Hudson M; Lesaffre E; Fu Y; Goodman S; Houbracken K; Munsters K; Granger CB; Pieper K; Califf RM; Topol EJ; Van De Werf F
    Circulation; 2001 Feb; 103(7):954-60. PubMed ID: 11181469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST Segment Monitoring Substudy.
    Langer A; Krucoff MW; Klootwijk P; Simoons ML; Granger CB; Barr A; Califf RM; Armstrong PW
    J Am Coll Cardiol; 1998 Mar; 31(4):783-9. PubMed ID: 9525547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.
    Granger CB; Becker R; Tracy RP; Califf RM; Topol EJ; Pieper KS; Ross AM; Roth S; Lambrew C; Bovill EG
    J Am Coll Cardiol; 1998 Mar; 31(3):497-505. PubMed ID: 9502626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of delays in presentation and treatment for patients with acute myocardial infarction: The GUSTO-I and GUSTO-III experience.
    Gibler WB; Armstrong PW; Ohman EM; Weaver WD; Stebbins AL; Gore JM; Newby LK; Califf RM; Topol EJ;
    Ann Emerg Med; 2002 Feb; 39(2):123-30. PubMed ID: 11823765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators.
    Simes RJ; Topol EJ; Holmes DR; White HD; Rutsch WR; Vahanian A; Simoons ML; Morris D; Betriu A; Califf RM
    Circulation; 1995 Apr; 91(7):1923-8. PubMed ID: 7895348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of resources, quality of life, and clinical outcomes in patients with and without new Q waves after thrombolytic therapy for acute myocardial infarction (from the GUSTO-I trial).
    Barbagelata A; Califf RM; Sgarbossa EB; Goodman SG; Knight D; Mark DB; Granger CB; Agranatti DA; Mautner B; Ohman EM; Suárez LD; Armstrong PW; Gates K; Wagner GS
    Am J Cardiol; 2000 Jul; 86(1):24-9. PubMed ID: 10867087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of gender-specific outcomes after thrombolytic therapy for acute myocardial infarction from the GUSTO-I trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Moen EK; Asher CR; Miller DP; Weaver WD; White HD; Califf RM; Topol EJ
    J Womens Health; 1997 Jun; 6(3):285-93. PubMed ID: 9201663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience.
    Woodfield SL; Lundergan CF; Reiner JS; Greenhouse SW; Thompson MA; Rohrbeck SC; Deychak Y; Simoons ML; Califf RM; Topol EJ; Ross AM
    J Am Coll Cardiol; 1996 Dec; 28(7):1661-9. PubMed ID: 8962549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Pilote L; Califf RM; Sapp S; Miller DP; Mark DB; Weaver WD; Gore JM; Armstrong PW; Ohman EM; Topol EJ
    N Engl J Med; 1995 Aug; 333(9):565-72. PubMed ID: 7623907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.